ask="6.350"
ask_size="200"
average_daily_volume="35557"
bid="5.690"
bid_size="100"
book_value="1.987"
change="+0.175"
change_from_200_day_moving_average="-0.648"
change_from_50_day_moving_average="0.296"
change_from_52_week_high="-3.975"
change_From_52_week_low="0.935"
change_in_percent="+2.752%"
close="6.535"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.868"
ebitda="-10.01M"
eps_estimate_current_year="-0.620"
eps_estimate_next_quarter="-0.130"
eps_estimate_next_year="-1.010"
ex_dividend_date="N/A"
float_shares="8645000"
high="6.560"
high_52_weeks="10.510"
last_trade_date="1/11/2017"
last_trade_price="6.535"
last_trade_size="100"
last_trade_time="3:58pm"
low="6.271"
low_52_weeks="5.600"
market_capitalization="86.68M"
moving_average_200_day="7.183"
moving_average_50_day="6.239"
name="Oramed Pharmaceuticals Inc."
notes="N/A"
one_year_target_price="18.000"
open="6.390"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="-9.027%"
percent_change_from_50_day_moving_average="+4.748%"
percent_change_from_52_week_high="-37.821%"
percent_change_from_52_week_low="+16.696%"
previous_close="6.360"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.201"
price_per_sales="131.606"
revenue="640999.00"
shares_outstanding="13264000"
short_ratio="6.220"
stock_exchange="NCM"
symbol="ORMP"
volume="15614"
weeks_range_52="5.600 - 10.510"
